Legal & General Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.63M | Buy |
114,932
+4,643
| +4% | +$147K | ﹤0.01% | 1692 |
|
|
2025
Q1 | $3.66M | Sell |
110,289
-6,670
| -6% | -$221K | ﹤0.01% | 1668 |
|
|
2024
Q4 | $4.02M | Buy |
116,959
+27,619
| +31% | +$950K | ﹤0.01% | 1685 |
|
|
2024
Q3 | $3.57M | Sell |
89,340
-2,855
| -3% | -$114K | ﹤0.01% | 1727 |
|
|
2024
Q2 | $2.78M | Sell |
92,195
-1,712
| -2% | -$51.7K | ﹤0.01% | 1791 |
|
|
2024
Q1 | $3.15M | Sell |
93,907
-459
| -0.5% | -$15.4K | ﹤0.01% | 1732 |
|
|
2023
Q4 | $3.05M | Sell |
94,366
-4,117
| -4% | -$133K | ﹤0.01% | 1744 |
|
|
2023
Q3 | $3.23M | Buy |
98,483
+9,657
| +11% | +$316K | ﹤0.01% | 1677 |
|
|
2023
Q2 | $3.13M | Buy |
88,826
+8,220
| +10% | +$289K | ﹤0.01% | 1707 |
|
|
2023
Q1 | $2.63M | Sell |
80,606
-1,027
| -1% | -$33.5K | ﹤0.01% | 1751 |
|
|
2022
Q4 | $4.5M | Buy |
81,633
+2,953
| +4% | +$163K | ﹤0.01% | 1456 |
|
|
2022
Q3 | $3.48M | Buy |
78,680
+18,252
| +30% | +$808K | ﹤0.01% | 1568 |
|
|
2022
Q2 | $2.95M | Buy |
60,428
+8,121
| +16% | +$396K | ﹤0.01% | 1687 |
|
|
2022
Q1 | $2.55M | Sell |
52,307
-322
| -0.6% | -$15.7K | ﹤0.01% | 1879 |
|
|
2021
Q4 | $2.25M | Buy |
52,629
+46,191
| +717% | +$1.97M | ﹤0.01% | 1984 |
|
|
2021
Q3 | $246K | Buy |
6,438
+3,340
| +108% | +$128K | ﹤0.01% | 2620 |
|
|
2021
Q2 | $88K | Buy |
3,098
+2,467
| +391% | +$70.1K | ﹤0.01% | 2779 |
|
|
2021
Q1 | $21K | Hold |
631
| – | – | ﹤0.01% | 3114 |
|
|
2020
Q4 | $23K | Buy |
+631
| New | +$23K | ﹤0.01% | 3036 |
|